Jefferies Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $9.23M | Buy |
+149,600
| New | +$9.43M | 0.08% | 206 |
|
|
2022
Q2 | – | Sell |
-347,600
| Closed | -$20.7M | – | 1656 |
|
|
2022
Q1 | $20.7M | Buy |
347,600
+132,800
| +62% | +$8.49M | 0.13% | 115 |
|
|
2021
Q4 | $15.6M | Buy |
214,800
+163,600
| +320% | +$11.3M | 0.09% | 181 |
|
|
2021
Q3 | $3.58M | Buy |
+51,200
| New | +$3.6M | 0.03% | 532 |
|
|
2021
Q1 | – | Sell |
-209,300
| Closed | -$12.2M | – | 1766 |
|
|
2020
Q4 | $12.2M | Buy |
209,300
+59,100
| +39% | +$3.57M | 0.1% | 175 |
|
|
2020
Q3 | $9.49M | Sell |
150,200
-223,300
| -60% | -$15.5M | 0.11% | 155 |
|
|
2020
Q2 | $28.7K | Sell |
373,500
-233,900
| -39% | -$17.9M | 0.34% | 33 |
|
|
2020
Q1 | $45.4M | Buy |
607,400
+52,400
| +9% | +$3.62M | 0.5% | 16 |
|
|
2019
Q4 | $36.1M | Buy |
555,000
+466,800
| +529% | +$30.4M | 0.28% | 52 |
|
|
2019
Q3 | $5.59M | Buy |
88,200
+63,000
| +250% | +$4.12M | 0.04% | 466 |
|
|
2019
Q2 | $1.7M | Sell |
25,200
-473,600
| -95% | -$31.2M | 0.01% | 1005 |
|
|
2019
Q1 | $32.4M | Buy |
498,800
+98,200
| +25% | +$6.53M | 0.27% | 41 |
|
|
2018
Q4 | $25.1M | Sell |
400,600
-78,800
| -16% | -$5.51M | 0.2% | 71 |
|
|
2018
Q3 | $37M | Buy |
479,400
+117,600
| +33% | +$8.88M | 0.24% | 56 |
|
|
2018
Q2 | $25.6M | Buy |
361,800
+328,200
| +977% | +$23.2M | 0.14% | 90 |
|
|
2018
Q1 | $2.53M | Buy |
33,600
+21,700
| +182% | +$1.73M | 0.01% | 744 |
|
|
2017
Q4 | $853K | Buy |
+11,900
| New | +$904K | ﹤0.01% | 1458 |
|
|
2017
Q3 | – | Sell |
-3,700
| Closed | -$262K | – | 2438 |
|
|
2017
Q2 | $262K | Sell |
3,700
-27,100
| -88% | -$1.8M | ﹤0.01% | 1935 |
|
|
2017
Q1 | $2.09M | Buy |
30,800
+26,100
| +555% | +$1.84M | 0.02% | 886 |
|
|
2016
Q4 | $337K | Sell |
4,700
-5,200
| -53% | -$387K | ﹤0.01% | 1724 |
|
|
2016
Q3 | $783K | Sell |
9,900
-60,400
| -86% | -$4.91M | ﹤0.01% | 1400 |
|
|
2016
Q2 | $5.86M | Buy |
70,300
+48,500
| +222% | +$4.3M | 0.03% | 447 |
|
|
2016
Q1 | $2M | Sell |
21,800
-350,500
| -94% | -$31.6M | 0.01% | 837 |
|
|
2015
Q4 | $37.7M | Buy |
372,300
+241,500
| +185% | +$25.1M | 0.21% | 80 |
|
|
2015
Q3 | $12.8M | Buy |
130,800
+30,000
| +30% | +$3.33M | 0.07% | 206 |
|
|
2015
Q2 | $11.8M | Buy |
100,800
+75,800
| +303% | +$8.28M | 0.06% | 258 |
|
|
2015
Q1 | $2.45M | Sell |
25,000
-99,300
| -80% | -$10.1M | 0.01% | 676 |
|
|
2014
Q4 | $11.7M | Buy |
124,300
+65,100
| +110% | +$6.73M | 0.07% | 240 |
|
|
2014
Q3 | $6.3M | Buy |
+59,200
| New | +$5.8M | 0.04% | 353 |
|
|
2014
Q2 | – | Sell |
-250,000
| Closed | -$17.7M | – | 2178 |
|
|
2014
Q1 | $17.7M | Buy |
250,000
+163,000
| +187% | +$12.8M | 0.17% | 107 |
|
|
2013
Q4 | $6.53M | Sell |
87,000
-16,000
| -16% | -$1.11M | 0.04% | 257 |
|
|
2013
Q3 | $6.48M | Buy |
103,000
+16,000
| +18% | +$956K | 0.06% | 262 |
|
|
2013
Q2 | $4.46M | Buy |
+87,000
| New | +$4.53M | 0.05% | 279 |
|
Other funds holding GILD
Jefferies Group's GILD Position: Q3 2022 in Review
Jefferies Group opened a new position in Gilead Sciences (GILD) in Q3 2022: 37,506 shares worth $2.31M. The stake represents 0.02% of the portfolio and ranks #555 among its holdings. This is a return to the name: Jefferies Group previously reported a position in GILD as recently as Q1 2022.
Jefferies Group first reported a position in GILD in Q2 2013 and has held it in 36 quarters since. The position peaked at $29.9M in Q4 2021. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.
- Jefferies Group held 37,506 shares of Gilead Sciences worth $2.31M as of Q3 2022.
- Gilead Sciences was a new Jefferies Group position in Q3 2022.
- Gilead Sciences made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #555 holding.
- Jefferies Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 36 quarters since.
- Jefferies Group's Gilead Sciences position peaked at $29.9M in Q4 2021.
- 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.